Insider · CIK 0001815428
Steve Forte
Files at RPTX (Repare Therapeutics Inc.). First filing Mar 14, 2025, latest Mar 14, 2025.
In brief
Steve Forte files SEC Form 4 as CFO at RPTX (Repare Therapeutics Inc.). Since Mar 14, 2025, Steve Forte has reported 0 open-market buys worth $0 and 1 open-market sell worth $7,848, the latest filed on Mar 14, 2025.
A track record needs three past buys with six months of prices behind them; Steve Forte has 0, so none is measured yet.
The newest scored trade: sold $7,848 of RPTX on Mar 12, 2025, filed Mar 14, 2025, scored 35 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Repare Therapeutics Inc. | $7,848 6,884 shares | -11% | - |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Common Shares | -56,786 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -200,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -85,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -500,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -325,800 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Apr 2, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Apr 4, 2025 |
| Mar 12, 2025 | RPTX Repare Therapeutics Inc. | SOpen-market sale Common Shares | -6,884 | $1.14 | $7,848 | 54,786 | Mar 14, 2025 |
| Mar 4, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Common Shares | +14,000 | $0.00 | $0 | 61,670 | Mar 6, 2025 |
| Mar 4, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Mar 6, 2025 |
| Mar 4, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Mar 6, 2025 |
Questions about Steve Forte
Answered from the filings on this page, as of the latest one.
Is Steve Forte buying or selling?
Not in the last 12 months. Steve Forte's latest open-market trade on SEC Form 4 was sold $7,848 of RPTX on Mar 12, 2025.
How did Steve Forte's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steve Forte has 0.
Where does Steve Forte file Form 4?
Steve Forte has filed Form 4 at RPTX (Repare Therapeutics Inc.) as EVP, CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.